News & Events about Mind Medicine Mindmed Inc.
MindMed Provides Corporate Update and 2023 Outlook MindMed Provides Corporate Update and 2023 Outlook PR Newswire NEW YORK, Jan. 9, 2023 - Company positioned for key MM-120 Phase 2b data readout in GAD and Phase 2a data readout in ADHD in late 2023 - Company to initiate first clinical trial...
CNW Group - News Releases
21days ago
MindMed Provides Corporate Update and 2023 Outlook MindMed Provides Corporate Update and 2023 Outlook Canada NewsWire NEW YORK, Jan. 9, 2023 - Company positioned for key MM-120 Phase 2b data readout in GAD and Phase 2a data readout in ADHD in late 2023 - Company to initiate first clinical trial...
MindMed to Participate in the Canaccord Genuity New Paradigms and Treatment Approaches in Mental Health Conference MindMed to Participate in the Canaccord Genuity New Paradigms and Treatment Approaches in Mental Health Conference PR Newswire NEW YORK, Dec. 1, 2022 NEW YORK, Dec. 1, 2022...
CNW Group - News Releases
2 months ago
MindMed to Participate in the Canaccord Genuity New Paradigms and Treatment Approaches in Mental Health Conference MindMed to Participate in the Canaccord Genuity New Paradigms and Treatment Approaches in Mental Health Conference Canada NewsWire NEW YORK, Dec. 1, 2022 NEW YORK, Dec. 1, 2022 /CNW...
MindMed to Participate in the Jefferies London Healthcare Conference MindMed to Participate in the Jefferies London Healthcare Conference PR Newswire NEW YORK, Nov. 11, 2022 NEW YORK, Nov. 11, 2022 /PRNewswire/ -- Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED), (the 'Company' or...